<DOC>
	<DOCNO>NCT02746302</DOCNO>
	<brief_summary>This trial conduct China . The aim trial ass safety tolerability HS-20004 healthy Chinese subject .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Pharmacodynamics HS-20004 Healthy Chinese Volunteers</brief_title>
	<detailed_description />
	<criteria>Body Mass Index ( BMI ) 19 24 kg/m^2， inclusive， total body weight least 50 kg ; Clinically relevant abnormality physical examination , laboratory value , vital sign ECG finding screen , judge Investigator Have medical abnormality ( cardiovascular , hepatic , renal , gastrointestinal , immunologic , hematological , hormonal , metabolic , neoplasmatic mental disease ) , opinion investigator , might affect absorption , distribution , metabolism , excretion study drug , prevent patient follow complete protocol Family history diabetes , thyroid cancer , submandibular gland cancer , history pancreatitis , cholelithiasis , drug allergy , serious unconscious hypoglycemia Hepatitis B surface antigen , Hepatitis C antibody HIV ( human immunodeficiency virus ) antibodies positive History drug alcohol abuse within 6 month randomization Use GLP1 analogue , DPPIV enzyme inhibitor , well hypoglycemic drug within 3 month randomization Use prescription drug Chinese herbal medicine within 4 week randomization Use non prescription drug food supplement ( vitamin , etc . ) within 2 week randomization Participated drug clinical trial within 3 month , participate 3 3 drug clinical trial near year , blood donation/loss &gt; 400mL within 3 month Female subject childbearing potential use acceptable method birth control , pregnant planning pregnancy , breastfeeding , male subject use acceptable method birth control , within six month randomization Subject refrain smoking , eat and/or drink contain xanthine/caffeine , strenuous exercise , others affect drug absorption , distribution , metabolism excretion within 2 day study drug administration Subject unsuitable inclusion study opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>